TBR1 and Hepatic fibrosis: For theAAV-TβR1 0W group and the combination therapy group, the degree of hepatic fibrosis in the rats was significantly reduced, which was indicated by a smaller extent of damage to normal liver structures and thin fibrous septa accompanied by unapparent cell degeneration and necrosis.